Decoy Therapeutics (FP11) Financial Statements
Decoy Therapeutics Financial Overview
Decoy Therapeutics's market cap is currently $2.28M. The company's EPS TTM is $-29.09; its P/E ratio is -0.04; Decoy Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -8.52M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -12.61M | $ -5.73M | $ -12.89M | $ -31.84M | $ -12.81M |
| EBITDA | $ -12.51M | $ -5.57M | $ -12.53M | $ -22.97M | $ -12.75M |
| Net Income | $ -12.52M | $ -5.58M | $ -12.54M | $ -31.61M | $ -12.77M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 10.71M | $ 2.43M | $ 5.90M | $ 12.11M | $ 29.21M |
| Total Assets | $ 11.06M | $ 3.02M | $ 6.59M | $ 14.65M | $ 40.83M |
| Total Debt | $ 0.00 | $ 221.87K | $ 289.64K | $ 0.00 | $ 0.00 |
| Net Debt | $ -10.71M | $ -2.21M | $ -5.61M | $ -12.11M | $ -29.21M |
| Total Liabilities | $ 5.17M | $ 1.51M | $ 1.30M | $ 4.27M | $ 2.11M |
| Stockholders' Equity | $ 5.89M | $ 1.51M | $ 5.29M | $ 10.38M | $ 38.72M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.83M | $ -4.53M | $ -12.85M | $ -19.10M | $ -10.20M |
| Operating Cash Flow | $ -4.83M | $ -4.53M | $ -12.85M | $ -17.60M | $ -10.20M |
| Investing Cash Flow | $ 764.74K | $ 0.00 | $ 0.00 | $ -1.50M | $ 0.00 |
| Financing Cash Flow | $ 12.34M | $ 1.06M | $ 6.64M | $ 1.99M | $ 28.30M |
Currency in USD